Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03220646
Title Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

glioblastoma

malignant astrocytoma

oligodendroglioma

meningioma

high grade glioma

central nervous system lymphoma

high grade ependymoma

Therapies

Abemaciclib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST